Oxford Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Oxford Asset Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,458	Closed	-$30.9K	–	454
2024 Q1	$30.9K	Buy	+19,458	New	+$28.9K	0.03%	252
2020 Q1	–	Sell	-70,552	Closed	-$1.3M	–	1436
2019 Q4	$1.3M	Buy	70,552 +58,463	+484%	+$855K	0.04%	696
2019 Q3	$167K	Buy	+12,089	New	+$181K	﹤0.01%	1594

Oxford Asset Management's NGM Position: Q2 2024 in Review

Oxford Asset Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 19,458 shares — an estimated $30.9K sold.

Oxford Asset Management first reported a position in NGM in Q3 2019 and held it in 3 quarters. The position peaked at $1.3M in Q4 2019. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Oxford Asset Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Oxford Asset Management sold 19,458 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $30.9K.
Oxford Asset Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Oxford Asset Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $1.3M in Q4 2019.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Oxford Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.